ES2061609T3 - 2',3'-dideoxi-2'-fluoro-nucleosidos. - Google Patents

2',3'-dideoxi-2'-fluoro-nucleosidos.

Info

Publication number
ES2061609T3
ES2061609T3 ES88118870T ES88118870T ES2061609T3 ES 2061609 T3 ES2061609 T3 ES 2061609T3 ES 88118870 T ES88118870 T ES 88118870T ES 88118870 T ES88118870 T ES 88118870T ES 2061609 T3 ES2061609 T3 ES 2061609T3
Authority
ES
Spain
Prior art keywords
dideoxi
nucleosides
fluoro
didesoxi
fluoronucleosides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88118870T
Other languages
English (en)
Inventor
Roman Z Sterzycki
Muzammil M Mansuri
John C Martin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of ES2061609T3 publication Critical patent/ES2061609T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/173—Purine radicals with 2-deoxyribosyl as the saccharide radical
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A NUEVOS 2'',3''- DIDESOXI FLUORONUCLEOSIDOS Y 2'',3''- DIDESOXI - 2'',3''- DIDESHIDRO 2''-FLUORONUCLEOSIDOS Y A PROCEDIMIENTOS PARA SU PREPARACION. LOS COMPUESTOS ASI PRODUCIDOS MUESTRAN EFECTOS ANTIVIRICOS Y MAS PARTICULARMENTE ANTI - HIV (VIRUS DE INMUNODEFICIENCIA HUMANA), TERAPEUTICAMENTE UTILES.
ES88118870T 1987-11-12 1988-11-11 2',3'-dideoxi-2'-fluoro-nucleosidos. Expired - Lifetime ES2061609T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/120,051 US4908440A (en) 1987-11-12 1987-11-12 2',3'-dideoxy-2'-fluoroarabinopyrimidine nucleosides

Publications (1)

Publication Number Publication Date
ES2061609T3 true ES2061609T3 (es) 1994-12-16

Family

ID=22387985

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88118870T Expired - Lifetime ES2061609T3 (es) 1987-11-12 1988-11-11 2',3'-dideoxi-2'-fluoro-nucleosidos.

Country Status (22)

Country Link
US (4) US4908440A (es)
EP (1) EP0316017B1 (es)
JP (4) JPH01153698A (es)
KR (1) KR920004459B1 (es)
AT (1) ATE100461T1 (es)
AU (1) AU615960B2 (es)
CA (1) CA1340961C (es)
CZ (3) CZ278366B6 (es)
DD (1) DD275874A5 (es)
DE (1) DE3887273T2 (es)
DK (1) DK173971B1 (es)
ES (1) ES2061609T3 (es)
FI (1) FI90244C (es)
HU (1) HU199499B (es)
IE (1) IE62227B1 (es)
IL (1) IL88330A (es)
NO (1) NO169492C (es)
NZ (1) NZ226845A (es)
PT (1) PT88994B (es)
SK (2) SK743188A3 (es)
YU (1) YU47121B (es)
ZA (1) ZA888313B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5459256A (en) * 1987-04-17 1995-10-17 The Government Of The United States Of America As Represented By The Department Of Health And Human Services Lipophilic, aminohydrolase-activated prodrugs
US5495010A (en) * 1987-04-17 1996-02-27 The United States Of America As Represented By The Department Of Health And Human Services Acid stable purine dideoxynucleosides
US5175292A (en) * 1988-01-20 1992-12-29 Regents Of The University Of Minnesota Intermediates for the preparation of dideoxycarbocyclic nucleosides
US5631370A (en) 1988-01-20 1997-05-20 Regents Of The University Of Minnesota Optically-active isomers of dideoxycarbocyclic nucleosides
US5644043A (en) * 1988-02-16 1997-07-01 Eli Lilly And Company 2',3'-dideoxy-2',2'-difluoronucleosides and intermediates
US5198539A (en) * 1988-08-19 1993-03-30 Burroughs Wellcome Co. 5'-esters of 2',3'-dideoxy-3'-fluoro-5-ethynyluridine
NZ232912A (en) * 1989-03-17 1992-06-25 Oncogen Ltd Lp Synergistic composition of nucleoside derivatives for inhibiting hiv
FI95384C (fi) * 1989-04-06 1996-01-25 Squibb Bristol Myers Co Menetelmä 3'-deoksi-3'-substituoitujen metyylinukleosidien valmistamiseksi ja menetelmässä käytettäviä välituotteita
SE464168B (sv) * 1989-07-19 1991-03-18 Bo Fredrik Oeberg Antiviral komposition bestaaende av en 3'-fluoro-2',3'-dideoxynukleosidfoerening och en 2',3'-dideoxynukleosidfoerening (exempelvis azt)
ES2253732T3 (es) * 1989-09-15 2006-06-01 Southern Research Institute 2'-deoxi-4'-tioribonucleosidos como agentes antivirales y anticancerosos.
US5817799A (en) * 1990-07-23 1998-10-06 The United States Of America As Represented By The Department Of Health And Human Services 2'-Fluorofuranosyl derivatives and methods for preparing 2'-fluoropyrimidine and 2'-fluoropurine nucleosides
US5420115A (en) * 1990-09-10 1995-05-30 Burroughs Wellcome Co. Method for the treatment of protoza infections with 21 -deoxy-21 -fluoropurine nucleosides
WO1992011276A1 (en) * 1990-12-18 1992-07-09 Sloan-Kettering Institute For Cancer Research Novel synthesis of 2'-'up' fluorinated 2''-deoxy-arabinofuranosylpurines
ZA923641B (en) * 1991-05-21 1993-02-24 Iaf Biochem Int Processes for the diastereoselective synthesis of nucleosides
US5712477A (en) * 1996-05-14 1998-01-27 Allen-Bradley Company, Inc. System to provide alignment and troubleshooting aid photoelectric sensors through alternating numeric display
EA200700564A1 (ru) 1998-02-25 2007-08-31 Эмори Юниверсити 2`-фторнуклеозиды
CN101240001B (zh) * 1998-02-25 2013-10-16 埃莫里大学 2'-氟代核苷
KR20090089922A (ko) 2000-10-18 2009-08-24 파마셋 인코포레이티드 바이러스 감염 및 비정상적인 세포 증식의 치료를 위한 변형된 뉴클레오시드
WO2003000200A2 (en) 2001-06-22 2003-01-03 Pharmasset Ltd. β-2'-OR 3'-HALONUCLEOSIDES
US20050131224A1 (en) * 2003-12-15 2005-06-16 Cti Pet Systems, Inc. Method for preparing radiolabeled thymidine
US7160537B2 (en) * 2003-12-15 2007-01-09 Siemens Medical Solutions Usa, Inc. Method for preparing radiolabeled thymidine having low chromophoric byproducts
US8895531B2 (en) 2006-03-23 2014-11-25 Rfs Pharma Llc 2′-fluoronucleoside phosphonates as antiviral agents
US20070243798A1 (en) * 2006-04-18 2007-10-18 3M Innovative Properties Company Embossed structured abrasive article and method of making and using the same
KR20160076373A (ko) 2014-12-22 2016-06-30 김기범 양식용 패각 고정을 위한 로프 어셈블리

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE292023C (es) *
US4211773A (en) * 1978-10-02 1980-07-08 Sloan Kettering Institute For Cancer Research 5-Substituted 1-(2'-Deoxy-2'-substituted-β-D-arabinofuranosyl)pyrimidine nucleosides
CA1340645C (en) * 1987-04-17 1999-07-13 Victor E. Marquez Acid stable dideoxynucleosides active against the cytopathic effects of human immunodeficiency virus
GB8712115D0 (en) * 1987-05-22 1987-06-24 Hoffmann La Roche Pyrimidine derivatives
JPH01100190A (ja) * 1987-10-12 1989-04-18 Asahi Glass Co Ltd ヌクレオシド類
NZ226672A (en) * 1987-10-30 1991-07-26 Hoffmann La Roche 6-amino-9-(2,3-dideoxy-2-fluoro-b-d-threopentofuranosyl)-9h-purine derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
DE3887273D1 (de) 1994-03-03
FI90244B (fi) 1993-09-30
DK173971B1 (da) 2002-03-18
JP2699049B2 (ja) 1998-01-19
JP2811561B2 (ja) 1998-10-15
HU199499B (en) 1990-02-28
EP0316017A2 (en) 1989-05-17
EP0316017B1 (en) 1994-01-19
HUT48266A (en) 1989-05-29
AU615960B2 (en) 1991-10-17
US4973677A (en) 1990-11-27
US5218106A (en) 1993-06-08
CZ278395B6 (en) 1993-12-15
US5126506A (en) 1992-06-30
FI885153L (fi) 1989-05-13
JPH0649091A (ja) 1994-02-22
KR920004459B1 (ko) 1992-06-05
DE3887273T2 (de) 1994-05-19
JPH0648947A (ja) 1994-02-22
JPH01153698A (ja) 1989-06-15
PT88994A (pt) 1989-09-14
CZ278366B6 (en) 1993-12-15
JPH09183731A (ja) 1997-07-15
YU204888A (en) 1990-04-30
KR890008161A (ko) 1989-07-10
CZ545290A3 (en) 1993-08-11
CZ743188A3 (en) 1993-08-11
SK277919B6 (en) 1995-08-09
NO884995L (no) 1989-05-16
IL88330A (en) 1995-03-15
DK631688A (da) 1989-05-13
YU47121B (sh) 1994-12-28
AU2504288A (en) 1989-05-25
CZ545190A3 (en) 1993-08-11
DK631688D0 (da) 1988-11-11
NO884995D0 (no) 1988-11-09
IE883406L (en) 1989-05-12
CZ278394B6 (en) 1993-12-15
NZ226845A (en) 1991-10-25
SK545290A3 (en) 1995-10-11
NO169492B (no) 1992-03-23
JP2699050B2 (ja) 1998-01-19
SK743188A3 (en) 1995-08-09
EP0316017A3 (en) 1990-05-30
NO169492C (no) 1993-01-12
IL88330A0 (en) 1989-06-30
ZA888313B (en) 1989-07-26
ATE100461T1 (de) 1994-02-15
SK278017B6 (en) 1995-10-11
FI90244C (fi) 1994-01-10
DD275874A5 (de) 1990-02-07
CA1340961C (en) 2000-04-18
FI885153A0 (fi) 1988-11-09
IE62227B1 (en) 1995-01-11
PT88994B (pt) 1995-03-31
US4908440A (en) 1990-03-13

Similar Documents

Publication Publication Date Title
ES2036199T3 (es) Procedimiento de obtencion de un preparado farmaceutico administrable a traves de una membrana corporal.
ES520985A0 (es) Procedimiento para la preparacion de nuevos 6,11-dihidrodibenzo (b,e)-tiepin-11-n-alcohilnorescopin-eteres cuaternarios.
MX6046E (es) Procedimiento para la preparacion de 4,5-diaril-2-nitro-imidazoles
IT1163001B (it) Procedimento per la preparazione di 4' epidaunorubicina 3', 4' diepidaunorubicina e corrispondenti analoghi della doxorubicina
PT88994A (pt) Processo para a preparacao de 2',3'-didesoxi-2'-fluoro-nucleosidos e de composicoes farmaceuticas que os contem
DK155714C (da) Fremgangsmaade til fremstilling af en steril, injicerbar, fysiologisk acceptabel oploesning af et roentgenkontrastmiddel, samt en oploesning af roentgenkontrastmidlet til brug ved fremgangsmaaden
ES2038650T3 (es) Procedimiento para preparar una composicion farmaceutica que comprende 3'-desoxitimidin-2'-eno-(3'-desoxi-2',3'-dideshidrotimidina) para tratar pacientes infectados con retrovirus.
MX5532E (es) Procedimiento mejorado para la preparacion de 6a,10a-cis-hexahidro dibenzo(b,d)piran-9-onas
MX6242E (es) Procedimiento para la preparacion de 1,2,3,5,tetrahidroimidazotienopirimidin-2-onas
ES496019A0 (es) Procedimiento para la preparacion de (2,2')-disulfuros de ditiazolilo
AR228011A1 (es) Procedimiento para la preparacion de derivados sustituidos de 2,5,5,8a-tetrametil-1,2,3,4,4a,5,6,7,8,8a-decahidronaftaleno-1-spiro-2'-(4',6',7'-sustituido-2',3'-dihidrobenzofurano)
DK0750616T3 (da) Syreadditionssalte af 2,3,4,5-tetrahydro-1H-3-benzazapinforbindelser
DE69111607D1 (de) Reine kristalline form von rifapentin.
ES511834A0 (es) "procedimiento para la preparacion de nuevas indolinonas".
AR222075A1 (es) Procedimiento de preparacion de 2',6'-dialquil-n-alcoximetil-2-cloro-acetanilida
IT1158450B (it) Procedimento per la preparazione dell'eritro-alfa-2-piperidil-2,8-bis-(trifluorometil)-4-chinolinmetanolo
MX5685E (es) Procedimiento para la preparacion de 4,5-diaril-2-(tio-substituido)-pirrol
NO871190L (no) Fremgangsmaate for fremstilling av farmakologisk aktive substituerte anilider.
EP0311108A3 (en) Anti-hiv active 3'-azido-2,6-diaminopurine-2',3'-dideoxyriboside
MX6009E (es) Procedimiento para la preparacion de tetrahidro-1,3,5-tiadiazin-4-onas
ES496879A0 (es) Procedimiento para la preparacion de nuevos analogos estruc-turales de 5,6-dihidroprostaciclina
MX5101E (es) Procedimiento para la preparacion de 2-(2',2',2',-trihalogenoetil)-4-halogenociclobutan-1-onas
MX5508E (es) Procedimiento para la preparacion de o-carbamoiloximas de 2,3-dihidro-4h-1-benzopiran-4-ona
MX4991E (es) Procedimiento para la preparacion de 2,4,diamino-5-tiobencilpirimidinas
FR2426050A1 (fr) Ethers de furylmethyloxime, leur preparation et leur utilisation comme pesticides

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 316017

Country of ref document: ES